The landscape of regulatory oversight for the dietary supplement industry is undergoing a significant transformation, with state-level legislation emerging as a dominant and potentially formidable challenge. Graham Rigby, head of the American Herbal Products Association (AHPA), articulated this concern during an interview at the recent SupplySide Global trade show, highlighting that the proliferation of state-specific laws could usher in an era of complex and potentially conflicting compliance requirements for manufacturers and distributors nationwide. Rigby pointed to the recent enactment of a California law restricting the sale of certain supplements to minors, a move that directly mirrors a similar legislative precedent set in New York, as a potential catalyst for a wave of imitative legislation across other states.
A Shifting Political Landscape and Its Regulatory Ramifications
Rigby’s assessment gained particular significance in the wake of the November 5, 2026, midterm elections, which saw a substantial victory for the Democratic Party. On the state level, this electoral success translated into a strengthened position, with Democrats securing a majority of gubernatorial seats (28 Democratic governors compared to 20 for the Republican Party, with outcomes in Alaska and Kansas pending final tallies). Furthermore, the Democratic Party achieved new majorities in ten additional state legislatures, with two more states showing a strong lean towards Democratic control as vote counts concluded.
Political analysts have long observed a general inclination among Democratic lawmakers to champion consumer protection regulations. The current political configuration, with a single party holding sway in numerous state legislatures and executive offices, significantly streamlines the legislative process. This consolidation of power could expedite the passage of new laws impacting the dietary supplement sector, potentially at a pace and scale not previously witnessed.
"The passage of the California law is going to inspire other states to do the same," Rigby stated, underscoring the domino effect he anticipates. This sentiment is rooted in the observation that when a prominent state like California enacts pioneering legislation, other states often follow suit, seeking to address perceived regulatory gaps or capitalize on public sentiment.
The Focus on Minors and the Debate Over Causation
The current surge in state-level legislation primarily targets the sale of supplements marketed for muscle building and weight loss to individuals under the age of 18. The impetus behind these restrictions stems from research, notably a body of work led by Professor Bryn Austin of Harvard University, which posits that the consumption of these products by minors exacerbates eating disorders.
However, this assertion has been met with considerable skepticism from within the industry. Experts in the field have publicly contested the scientific validity of the causal link claimed by Austin and her research team. Their argument centers on the distinction between association and causation, suggesting that while young individuals using these supplements might also exhibit disordered eating patterns, the supplements themselves are not necessarily the primary drivers of such behaviors. Instead, they propose that the observed correlation may be a consequence of underlying predispositions or a broader constellation of lifestyle factors.
Despite these industry counterarguments, Professor Austin and the researchers she has mentored have evidently found receptive ears among state lawmakers. These legislators appear to believe that the U.S. Food and Drug Administration (FDA), the federal agency formally entrusted with regulating dietary supplements, is not adequately fulfilling its mandate. This perception of federal inaction or insufficiency has created an opening for state governments to step in and implement their own regulatory frameworks.
Impact on Youth Athletes and the Practical Challenges
Beyond the direct consumer protection argument, Rigby highlighted a less discussed but significant consequence of this legislative trend: its potential to complicate the lives of families dedicated to supporting the athletic development of young individuals. "Youth sports are becoming more competitive all the time," he observed, a sentiment that resonates with the increasing emphasis on specialized training and performance enhancement for aspiring teenage athletes.
For these young athletes, complex supplementation regimens have become increasingly common as they strive for peak performance. Rigby argued that imposing restrictions on the purchase of essential products like protein powders and creatine, particularly in the absence of robust scientific evidence demonstrating their inherent harm to this demographic, represents an undue imposition. He characterized it as an infringement on the freedom of families to make choices that they deem beneficial for their children’s athletic pursuits, a dimension of the issue that he believes warrants greater public attention.
Lisa Thomas, chief commercialization officer for herbal ingredient supplier Nuherbs, echoed Rigby’s concerns. Drawing from her own experience as an elite youth soccer player who managed her career and travel from a young age, Thomas articulated the practical difficulties such legislation could create. "I was driving myself to training 20 hours a week," she recalled. "Imagine if I would have had to get my parents to buy all my supplements at the same time." Her statement underscores the potential burden placed on both parents and young athletes, requiring additional logistical and financial considerations that could impede athletic development.
Expanding Regulatory Horizons: Beyond Age Restrictions
Rigby emphasized that the age restriction debate is merely the vanguard of a broader movement towards increased state-level intervention in the dietary supplement market. He asserted that state legislatures are demonstrating an unprecedented level of proactivity in addressing food and supplement-related legislation.
A notable example of this expanding scope is California’s recent passage of a bill mandating the testing of protein powders for heavy metal contamination. According to State Senator Steve Padilla, the bill’s sponsor, the rationale behind this state-level initiative was the perceived inadequacy of federal oversight. The law is slated to take effect in 2027.
Senator Padilla articulated his reasoning, stating, "[A]cross a rapidly expanding supplement market, oversight has not kept pace with growth, leaving gaps in transparency and accountability." This statement reflects a growing sentiment among some policymakers that federal regulatory bodies are not keeping pace with the dynamic and rapidly evolving dietary supplement industry.
The implications of such state-specific mandates are far-reaching for businesses operating within the sector. Rigby cautioned that companies might soon face the daunting prospect of needing to develop dozens of distinct product labels for the same supplement, each tailored to comply with the unique stipulations of various state laws. This would necessitate meticulous tracking of compliance across a patchwork of potentially conflicting regulations. The complexity is amplified by the fact that many of these laws target not only finished products but also individual ingredients. Consequently, any product containing a regulated ingredient could be subject to the law’s provisions, regardless of its primary function.
Rigby predicts that just as the age-restriction laws are likely to be emulated, Senator Padilla’s protein powder testing bill could also serve as a template for similar legislation in other states. This projected trend suggests a future where the dietary supplement industry navigates a significantly more fragmented and demanding regulatory environment.
The Path Forward: Industry Response and Future Outlook
In light of these escalating challenges, Rigby stressed the imperative for proactive engagement from industry stakeholders. He indicated that a concerted effort involving industry trade organizations, manufacturers, distributors, and other key players will be essential to navigate and potentially mitigate the impact of this evolving regulatory landscape. "It will require cooperation and vigilance on the part of industry trade organizations and other stakeholders to attempt to put this genie back into the bottle," Rigby stated, underscoring the urgency and complexity of the situation.
The current trajectory suggests a sustained period of regulatory flux. Rigby concluded his remarks with a sobering outlook: "Everything is on the table now. This will be an issue going into 2027 and beyond." This statement signals that the dietary supplement industry must prepare for a prolonged period of adaptation and strategic response to a growing number of state-driven regulatory initiatives. The industry’s ability to effectively advocate for science-based policy, engage in constructive dialogue with lawmakers, and demonstrate its commitment to consumer safety will be critical in shaping its future regulatory environment. The shift from federal dominance to a state-centric regulatory model presents a profound challenge, demanding a new level of strategic planning and coordinated action from all involved.
